BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27442601)

  • 1. Lung Function Abnormalities in Smokers with Ischemic Heart Disease.
    Franssen FM; Soriano JB; Roche N; Bloomfield PH; Brusselle G; Fabbri LM; García-Rio F; Kearney MT; Kwon N; Lundbäck B; Rabe KF; Raillard A; Muellerova H; Cockcroft JR
    Am J Respir Crit Care Med; 2016 Sep; 194(5):568-76. PubMed ID: 27442601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan.
    Onishi K; Yoshimoto D; Hagan GW; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2014; 9():563-8. PubMed ID: 24920894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.
    Yangui F; Touil A; Antit S; Zakhama L; Charfi MR
    Respir Med; 2021 Apr; 179():106335. PubMed ID: 33621707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Airflow Limitation Defined by Pre- and Post-Bronchodilator Spirometry in a Community-Based Health Checkup: The Hisayama Study.
    Fukuyama S; Matsumoto K; Kaneko Y; Kan-o K; Noda N; Tajiri-Asai Y; Nakano T; Ishii Y; Kiyohara Y; Nakanishi Y; Inoue H;
    Tohoku J Exp Med; 2016 Feb; 238(2):179-84. PubMed ID: 26888697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
    Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
    Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
    Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
    Mitsiki E; Bania E; Varounis C; Gourgoulianis KI; Alexopoulos EC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1371-82. PubMed ID: 26229456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study.
    Ogata H; Hirakawa Y; Matsumoto K; Hata J; Yoshida D; Fukuyama S; Inoue H; Kitazono T; Ninomiya T; Nakanishi Y
    BMJ Open; 2019 Mar; 9(3):e023673. PubMed ID: 30898804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.
    Costiniuk CT; Nitulescu R; Saneei Z; Wasef N; Salahuddin S; Wasef D; Young J; de Castro C; Routy JP; Lebouché B; Cox J; Smith BM; Ambroise S; Pexos C; Patel M; Szabo J; Haraoui LP; de Pokomandy A; Tsoukas C; Falutz J; LeBlanc R; Giannakis A; Frenette C; Jenabian MA; Bourbeau J; Klein MB
    HIV Med; 2019 Mar; 20(3):192-201. PubMed ID: 30620136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 17. Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.
    Donovan LM; Rise PJ; Carson SS; Feemster LC; Griffith MF; Kapur VK; Krishnan JA; Lindenauer PK; Mularski RA; Naureckas ET; Palen BN; Parsons EC; Spece LJ; Vitiello MV; Au DH;
    Ann Am Thorac Soc; 2017 Dec; 14(12):1836-1843. PubMed ID: 28825846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan - Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J).
    Omori H; Higashi N; Nawa T; Fukui T; Kaise T; Suzuki T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3039-3050. PubMed ID: 33262583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of airflow obstruction in patients with stable systolic heart failure.
    Dalsgaard M; Plesner LL; Schou M; Kjøller E; Vestbo J; Iversen K
    BMC Pulm Med; 2017 Jan; 17(1):6. PubMed ID: 28061834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.